Alembic Pharmaceuticals Limited (APLLTD-NS) Stock Split, History Data
Working capital analysis
In terms of working capital, Alembic Pharmaceuticals Limited maintains a healthy position.
The total current assets of the company are valued at $29100200000.
This represents a growth rate of 1.721% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $754800000, exhibiting a growth rate of 23.555% year-on-year.
The receivables, another significant portion of the current assets, are valued at $11291100000.
The year-on-year growth rate for receivables is -5.118%.
The inventory, which forms a critical part of the assets, is valued at $14752700000.
This represents a healthy year-on-year growth of -8.351%
On the liabilities side, the company's current liabilities total $16369300000.
This reflects a growth rate of -4.637% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
754.80
610.90
980.60
718.40
1990.70
837.50
Receavebles
11291.10
11900.10
8067.30
12033.60
6152.60
7268.10
Inventory
14752.70
16097.00
14861.50
11875.30
9672.60
7339.30
Other
2135.20
0.1
0.1
0.20
1761.40
2680.80
Total Current Assets
29100.20
28607.90
25779.00
24627.50
19577.30
18247.50
Acc Payable
6798.10
7063.90
6687.70
6259.30
50.90
2.00
Short Term Debt
6527.90
6449.70
3121.80
8704.00
6291.30
2077.80
Other Current Liab
855.40
0.1
0.20
418.90
213.50
9155.10
Current Liabilities
16369.30
17165.30
12808.40
17516.00
14896.30
11234.90
Capital Structure
When examining the capital structure of Alembic Pharmaceuticals Limited, it is clear that the company manages a robust portfolio.
These earnings represent the profits that Alembic Pharmaceuticals Limited has chosen to reinvest in the business rather than distribute as dividends.
